NO20075690L - Avlevering av tigesyklin i naervaer av heparin - Google Patents

Avlevering av tigesyklin i naervaer av heparin

Info

Publication number: NO20075690L
Authority: NO; Norway
Prior art keywords: heparin; tiger; cyclin; delivery; tigecycline
Prior art date: 2005-05-06

Application number

NO20075690A

Other languages

English (en)

Norwegian (no)

Inventor

Pooja Gandhi

Stephen A Ludwig

Maja Vencl-Joncic

Joseph Gross

Julianna Koczone

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-06

Filing date

2007-11-08

Publication date

2008-01-31

2007-11-08 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-01-31 Publication of NO20075690L publication Critical patent/NO20075690L/no

Links

HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 3
229960002897 heparin Drugs 0.000 title abstract 3
229920000669 heparin Polymers 0.000 title abstract 3
102000016736 Cyclin Human genes 0.000 title 1
108050006400 Cyclin Proteins 0.000 title 1
241000282376 Panthera tigris Species 0.000 title 1
FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 abstract 2
229960004089 tigecycline Drugs 0.000 abstract 2
238000002648 combination therapy Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

NO20075690A 2005-05-06 2007-11-08 Avlevering av tigesyklin i naervaer av heparin NO20075690L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US67820305P	2005-05-06	2005-05-06
PCT/US2006/016860 WO2006121713A2 (en)	2005-05-06	2006-05-02	Delivery of tigecycline in the presence of heparin

Publications (1)

Publication Number	Publication Date
NO20075690L true NO20075690L (no)	2008-01-31

Family

ID=36973003

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20075690A NO20075690L (no)	2005-05-06	2007-11-08	Avlevering av tigesyklin i naervaer av heparin

Country Status (14)

Country	Link
US (1)	US20060251705A1 (pt)
EP (1)	EP1877064A2 (pt)
JP (1)	JP2008540431A (pt)
KR (1)	KR20080005599A (pt)
CN (1)	CN101171016A (pt)
AU (1)	AU2006244588A1 (pt)
BR (1)	BRPI0611070A2 (pt)
CA (1)	CA2607143A1 (pt)
CR (1)	CR9491A (pt)
MX (1)	MX2007013895A (pt)
NO (1)	NO20075690L (pt)
RU (1)	RU2007140956A (pt)
WO (1)	WO2006121713A2 (pt)
ZA (1)	ZA200709510B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102595895B1 (ko) *	2015-11-27	2023-10-31	삼성전자 주식회사	상황인식 리소스 핫플러그 관리 시스템 및 방법
WO2019139877A1 (en) *	2018-01-10	2019-07-18	The University Of North Carolina At Chapel Hill	Tigecycline for topical treatment of root canal space
CN117599320A (zh)	2018-10-23	2024-02-27	艾比科生物医学公司	输送装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5494903A (en) *	1991-10-04	1996-02-27	American Cyanamid Company	7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
ES2245698T3 (es) *	2000-06-30	2006-01-16	PHARMACIA & UPJOHN COMPANY LLC	Composiciones para el tratamiento de infecciones bacterianas que contienen un compuesto de oxazolidinona, sulbactam y ampicilina.
RU2008121238A (ru) *	2005-12-22	2010-01-27	Вайет (Us)	Способы лечения инфекций желудочно-кишечного тракта с применением тайгециклина

2006
- 2006-05-02 KR KR1020077028116A patent/KR20080005599A/ko not_active Withdrawn
- 2006-05-02 CN CNA2006800155167A patent/CN101171016A/zh active Pending
- 2006-05-02 EP EP06758939A patent/EP1877064A2/en not_active Withdrawn
- 2006-05-02 JP JP2008510140A patent/JP2008540431A/ja not_active Withdrawn
- 2006-05-02 RU RU2007140956/15A patent/RU2007140956A/ru not_active Application Discontinuation
- 2006-05-02 BR BRPI0611070-3A patent/BRPI0611070A2/pt not_active Application Discontinuation
- 2006-05-02 WO PCT/US2006/016860 patent/WO2006121713A2/en not_active Ceased
- 2006-05-02 AU AU2006244588A patent/AU2006244588A1/en not_active Abandoned
- 2006-05-02 CA CA002607143A patent/CA2607143A1/en not_active Abandoned
- 2006-05-02 MX MX2007013895A patent/MX2007013895A/es unknown
- 2006-05-05 US US11/418,999 patent/US20060251705A1/en not_active Abandoned
2007
- 2007-10-31 CR CR9491A patent/CR9491A/es not_active Application Discontinuation
- 2007-11-05 ZA ZA200709510A patent/ZA200709510B/xx unknown
- 2007-11-08 NO NO20075690A patent/NO20075690L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN101171016A (zh)	2008-04-30
MX2007013895A (es)	2008-01-28
WO2006121713A3 (en)	2007-03-22
ZA200709510B (en)	2008-11-26
WO2006121713A2 (en)	2006-11-16
US20060251705A1 (en)	2006-11-09
BRPI0611070A2 (pt)	2010-08-03
EP1877064A2 (en)	2008-01-16
CR9491A (es)	2008-02-21
AU2006244588A1 (en)	2006-11-16
JP2008540431A (ja)	2008-11-20
RU2007140956A (ru)	2009-06-20
KR20080005599A (ko)	2008-01-14
CA2607143A1 (en)	2006-11-16

Similar Documents

Publication	Publication Date	Title
EA200870185A1 (ru)	2008-12-30	Комбинации ингибиторов ang2 и vegf
TW200744568A (en)	2007-12-16	Epinephrine dosing regimens
PH12017502286A1 (en)	2019-11-11	Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
NO20092637L (no)	2009-09-11	Fremgangsmater for behandling
PH12014500053A1 (en)	2015-03-30	Proteasome inhibitors
NO20170633A1 (no)	2008-02-07	Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
MY160041A (en)	2017-02-15	Compositions and methods for treating parasitic infections
UA118248C2 (uk)	2018-12-26	Інгібітори глюкозилцерамідсинтази
MA32161B1 (fr)	2011-03-01	Formes de rifaximine et utilisations de celles-ci
CL2010001426A1 (es)	2011-07-15	Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas.
EA201101521A1 (ru)	2012-09-28	Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
MX2009006704A (es)	2009-06-30	Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
TW200716646A (en)	2007-05-01	(S)-N-methylnaltrexone
MX2015002371A (es)	2015-10-05	Inhibidores bivalentes de las proteinas iap y metodos terapueticos que usan los mismos.
PH12018500641A1 (en)	2019-07-29	Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
EA201390803A1 (ru)	2013-09-30	Ингибиторы бромодомена и их применение
AR048819A1 (es)	2006-05-31	Metodos sinergicos y composiciones para el tratamiento del cancer
MX2018013333A (es)	2020-11-12	Composiciones de nucleasas terapeuticas y metodos.
MY149957A (en)	2013-11-15	Heterocyclic inhibitors of mek and methods of use thereof
NO20082120L (no)	2008-06-18	Behandling og forebyggelse av mikroangiopati
ATE489371T1 (de)	2010-12-15	Benzamidglucokinaseaktivatoren
MX2010006206A (es)	2011-03-04	Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MY149606A (en)	2013-09-13	Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
IN2014DN08385A (pt)	2015-05-08
NO20074780L (no)	2007-11-01	Heterocyklylamidsubstituerte imidazoler

Legal Events

Date	Code	Title	Description
2009-12-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application